EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Recent advanced lipid-based nanomedicines for overcoming cancer resistance

Piroonrat Dechbumroong, Runjing Hu, Wisawat Keaswejjareansuk, Katawut Namdee, Xing-Jie Liang

Cancer Drug Resistance · 21.06.2024

DOI: 10.20517/cdr.2024.19 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Drug Resistance, online erschienen am 21.06.2024. Verfasst von Piroonrat Dechbumroong und 4 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience …. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The increasing prevalence of cancer drug resistance not only critically limits the efficiency of traditional therapies but also causes relapses or recurrences of cancer. Consequently, there remains an urgent need to address the intricate landscape of drug resistance beyond traditional cancer therapies. Recently, nanotechnology has played an important role in the field of various drug delivery systems for the treatment of cancer, especially therapy-resistant cancer. Among advanced nanomedicine technologies, lipid-based nanomaterials have emerged as effective drug carriers for cancer treatment, significantly improving therapeutic effects. Due to their biocompatibility, simplicity of preparation, and potential for functionalization, lipid-based nanomaterials are considered powerful competitors for resistant cancer. In this review, an overview of lipid-based nanomaterials for addressing cancer resistance is discussed. We summarize the recent progress in overcoming drug resistance in cancer by these lipid-based nanomaterials, and highlight their potential in future applications to reverse cancer resistance.

Schlagwörter

Stichwörter der Autor:innen

Cancer resistancedrug deliverylipid-based nanomaterialsnanomedicines

Autor:innen und Institutionen

  • CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing 100049, China.
  • School of Nanoscience and Engineering, University of Chinese Academy of Sciences, Beijing 100049, China.
  • National Nanotechnology Center (NANOTEC), National Science and Technology Development Agency, Pathum Thani 12120, Thailand.
  • Authors contributed equally.

Zitieren

APA

Dechbumroong, P., Hu, R., Keaswejjareansuk, W., Namdee, K., & Liang, X. J. (2024). Recent advanced lipid-based nanomedicines for overcoming cancer resistance. Cancer Drug Resistance. https://doi.org/10.20517/cdr.2024.19

Vancouver

Dechbumroong P, Hu R, Keaswejjareansuk W, Namdee K, Liang XJ. Recent advanced lipid-based nanomedicines for overcoming cancer resistance. Cancer Drug Resistance. 2024. doi:10.20517/cdr.2024.19

BibTeX
@article{Dechbumroong2024,
  author = {Dechbumroong, Piroonrat and Hu, Runjing and Keaswejjareansuk, Wisawat and Namdee, Katawut and Liang, Xing-Jie},
  title = {Recent advanced lipid-based nanomedicines for overcoming cancer resistance},
  journal = {Cancer Drug Resistance},
  year = {2024},
  doi = {10.20517/cdr.2024.19}
}
Kostenlos starten →